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Introduction
Although PKA has been extensively studied for decades, the 
focus has mainly been on its catalytic subunit activity or the PKA 
holoenzyme  (heterotetramers  of  regulatory  and  catalytic  sub-
units). The role of its regulatory subunits (R-subunits) that is inde-
pendent of the PKA catalytic subunits (PKAc’s) has not been well 
characterized. The classically known functions of R-subunits are 
to inhibit PKAc and facilitate in targeting PKAc to compartmen-
talized regions of the cell by binding to A-kinase–anchoring pro-
teins (AKAPs) at its N-terminal domain (dimerization/docking 
[D/D] domain). Through the binding of cAMP at the C-terminal 
domains of R-subunits, PKAc is released from the holoenzyme 
complex and activated to phosphorylate downstream substrates.
Two  general  classes  of  R-subunits  exist,  RI  and  RII 
(Reimann et al., 1971), which can be further resolved at the ge-
netic level into four separate gene products: RI, RI, RII, 
and RII (Lee et al., 1983; Jahnsen et al., 1986; Scott et al., 
1987; Clegg et al., 1988). Although over 50 AKAPs have been 
identified (Wong and Scott, 2004), the majority of them bind to 
RII subunits so that RII subunits are typically associated with 
membranous organelles. Meanwhile, because RI subunits are 
mainly diffused in the cytoplasm, the localization of the RI holo-
enzyme has received less attention and is not well appreciated. 
Several studies have indicated that RI, probably associated 
with PKAc, can be recruited to specific sites, for example, to the 
“cap” site of activated T lymphocytes (Levy et al., 1996). The 
RI holoenzyme also localized to microtubules during the entire 
cell cycle (Imaizumi-Scherrer et al., 2001) and to protrusions at 
the front of migrating cells through its interaction with 4 inte-
grin (Lim et al., 2007).
A
lthough RII protein kinase A (PKA) regulatory sub-
units are constitutively localized to discrete cellu-
lar compartments through binding to A-kinase– 
anchoring  proteins  (AKAPs),  RI  subunits  are  primarily 
diffuse in the cytoplasm. In this paper, we report a novel 
AKAP-dependent localization of RI to distinct organelles, 
specifically, multivesicular bodies (MVBs). This localization 
depends on binding to AKAP11, which binds tightly to free 
RI or RI in complex with catalytic subunit (holoenzyme). 
However, recruitment to MVBs occurs only with the re-
lease of PKA catalytic subunit (PKAc). This recruitment is 
reversed by reassociation with PKAc, and it is disrupted 
by  the  presence  of  AKAP  peptides,  mutations  in  the   
RI AKAP-binding site, or knockdown of AKAP11. Cyclic 
adenosine  monophosphate  binding  not  only  unleashes 
active PKAc but also leads to the targeting of AKAP11:RI 
to MVBs. Therefore, we show that the RI holoenzyme   
is part of a signaling complex with AKAP11, in which 
AKAP11 may direct RI functionality after disassocia-
tion from PKAc. This model defines a new paradigm for 
PKA signaling.
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(MEFs), we showed that these puncta were RI specific. Further-
more, we established that it was free RI subunit that was re-
quired for formation, as overexpressed RI holoenzyme was 
cytoplasmic and showed no evidence of puncta formation. Upon 
stimulation with forskolin/isobutylmethylxanthine (IBMX), how-
ever, puncta formation occurred and was reversible for up to 3 h. 
Using fractionation and correlated light and electron micros-
copy, we established that RI puncta localized to multivesicular 
bodies  (MVBs). Through  mutagenesis  experiments  or  co-
expression with isoform-specific AKAP-disrupting peptides, we 
demonstrated that AKAP binding was essential for this localiza-
tion. In addition, our knockdown experiments established that   
it required a specific AKAP, AKAP11 (also known as AKAP220). 
Finally, we determined that the endogenous RI holoenzyme, 
though diffuse in the cytoplasm, was still tightly associated with 
AKAP11; however, translocation to MVBs only occurred when 
PKAc was released. Therefore, in contrast to RII subunits, which 
appear constitutively localized to discrete regions of the cell via 
high affinity binding to AKAPs, RI is assembled with AKAP11 
as  a  soluble  and  cytoplasmic  signaling  complex. Then,  upon 
stimulation with cAMP, AKAP11:RI can be dynamically re-
cruited to specific sites. We thus show that AKAP11 is highly 
specific for RI and also define a new paradigm for RI signaling 
and targeting through AKAP-mediated mechanisms.
Results
Punctate pattern of overexpressed RI is 
RI specific
Type  I  PKA  holoenzyme  and  free  RI  are  predominantly 
thought to be cytoplasmic; however, when we expressed GFP-
tagged RI in HeLa cells, we found a distinct punctate pattern 
(Fig. 1 A, top right). When we expressed RI in RI knockout 
MEFs (Prkar1a
/ MEFs), we saw a similar punctate pattern 
(Fig. 1 A, bottom right). In both cell lines, we observed the 
punctate pattern even when expression levels were low. To further 
confirm that puncta formation was not an artifact of overexpres-
sion, we used quantitative Western blot analysis to compare the 
levels of transfected RI-GFP in Prkar1a
/ MEFs to endog-
enous levels of RI in Prkar1a
+/+ MEFs (Fig. S1). Transfection 
efficiency of RI-GFP in Prkar1a
/ MEFs was typically around 
15–30%. Based on this efficiency and the difference in band in-
tensities between RI-GFP versus endogenous RI (15.4-fold 
for experiment 1 and 18.1-fold for experiment 2), the expres-
sion levels of RI-GFP with 100% transfection efficiency would 
range from 2.3- to 5.4-fold lower than the levels of endogenous 
RI.  Although  these  values  are  approximations,  the  results 
clearly demonstrate that RI-GFP was not overexpressed in   
relation to the levels of endogenous RI in Prkar1a
+/+ MEFs. In 
the remainder of this paper, the term “overexpression” is still 
used to indicate exogenous expression but is not indicative of 
the true levels of expression.
Four isoforms of the PKA R-subunits exist, and they dis-
play different localization patterns. We therefore next explored 
whether puncta formation was common to all R-subunits or unique 
to the RI isoform. Constructs of the four R-subunit isoforms   
were expressed in HeLa cells and Prkar1a
/ MEFs (Fig. 1 B).   
Although free RI was previously reported to be less stable 
when not in complex with PKAc (Steinberg and Agard, 1981; 
Orellana and McKnight, 1990), more recent studies have re-
vealed that free RI subunits localize to subcellular sites beyond 
the cytoplasm. For example, some studies have shown the asso-
ciation of RI with membranes (Rubin, 1979; Boeshans et al., 
1999). Another study reported that, independent of PKAc, the   
N terminus of RI, but not RII, was needed to bind RFC40 and 
transport it into the nucleus (Gupte et al., 2005). In addition, this 
translocation from the cytoplasm to the nucleus has been corre-
lated with the formation of the interchain disulfide bonds found 
in the D/D domain of RI but not found in RII (Brennan et al., 
2006). Mavrakis et al. (2006) also reported the localization of 
RI to late endosomes and autophagosomes.
Because the function of a protein is closely linked to its 
subcellular location, the different localizations of R-subunit iso-
forms could explain some of their known functional differences. 
RI is the only isoform that acted as a tissue-specific extin-
guisher (Boshart et al., 1991; Jones et al., 1991) and the only 
one that has been pursued as an anticancer drug target (Chen   
et al., 2000; Goel et al., 2006). Its down-regulation or over-
expression  disrupted  normal  cell  cycle  progression  (Tortora   
et al., 1994a,b). It was also the only isoform that resulted in em-
bryonic lethality when deleted in mice (Amieux and McKnight, 
2002). On the other hand, deletion of RI resulted in defects in 
hippocampal function (Brandon et al., 1995). Deletion of RII 
showed  no  gross  organ  dysfunction  (Burton  et  al.,  1999), 
whereas deletion of RII resulted in several changes, such as a 
lean phenotype with elevated body temperatures and meta-
bolic rates (McKnight et al., 1998) or a decreased sensitivity to   
increased ethanol consumption (Thiele et al., 2000). Thus, 
although four isoforms of the R-subunits exist, they are not 
functionally redundant.
RI is also the only isoform that can compensate for ex-
cess PKAc activity. When PKAc was overexpressed in NIH 3T3 
cells, RI levels increased with no change in RII subunit levels 
(Uhler and McKnight, 1987). RI knockout mice were no 
longer embryonically lethal when PKAc was also knocked out, 
but the double knockout mice displayed developmental defects 
later in life (Amieux and McKnight, 2002). Thus, a tightly co-
ordinated regulation exists between RI and PKAc that is cru-
cial for normal development.
RI may also have functions independent of PKAc. Over-
expression of RI is associated with breast cancer (Miller, 
2002), whereas underexpression of RI is linked to systemic   
lupus erythematosus (Kammer et al., 1996; Laxminarayana et al., 
1999) and Carney complex (Kirschner et al., 2000). Mutations 
in RI that did not affect RI expression levels or PKAc activ-
ity still resulted in Carney complex (Veugelers et al., 2004). In 
light of these findings, the localization of RI in the absence of 
PKAc is important to characterize.
In this study, we investigate a novel localization of RI 
that was observed after expression in mammalian cells. In con-
trast to the other proteins we expressed, RI formed puncta. 
The aims of our study were to characterize these puncta and de-
termine their requirements for formation. By expressing RI-
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Figure 1.  Expression of wild-type RI in mammalian cells revealed a punctate pattern that is RI specific. (A) Transient transfection of control GFP empty 
vector or GFP-tagged RI in HeLa cells (top) and Prkar1a
/ MEFs (bottom). (B) Expression of fluorescently tagged R-subunit isoforms in HeLa cells (top) 
and Prkar1a
/ MEFs (bottom). (C) Coexpression of control GFP empty vector or GFP-tagged RI with mCherry-tagged PKAc in Prkar1a
/ MEFs without 
treatment (left) and with 20 µM forskolin/200 µM IBMX treatment (right). Labels in the top left corner of each image indicate which protein is observed.   
(D) Representative frames from Video 1 showing Prkar1a
/ MEFs transiently transfected with GFP-tagged RI (green) and mCherry-tagged PKAc (red).   
10 µM H89 was added to inhibit PKAc activity (last representative frame). (E) Representative frames from Video 3 showing Prkar1a
/ MEFs transiently 
transfected with GFP-tagged RI (green), mCherry-tagged PKAc (red), and CFP-tagged PKI (blue). (D and E) Baseline represents the cell before any treat-
ment, whereas postwash represents the cell after removal of treatment. 20 µM forskolin/200 µM IBMX was added to activate PKAc. DIC, differential 
interference contrast. wt, wild type. FSK, forskolin. Bars, 20 µm.JCB • VOLUME 193 • NUMBER 2 • 2011   350
pattern diminished but never became fully diffuse. Then, the 
strong punctate pattern reappeared within 3 min of adding a 
second round of forskolin/IBMX. This result indicated that any 
diffuse pattern observed during postwash was not simply a re-
sult of targeting RI for rapid degradation (Video 2).
Punctate pattern is independent of PKAc 
activity and irreversible in the presence of 
a protein kinase inhibitor (PKI)
Upon activation, PKAc is released to phosphorylate downstream 
substrates. We therefore wanted to determine whether PKAc   
activity was required for puncta formation. When the cells from 
Video 1 displayed a diffuse pattern after undergoing two rounds 
of forskolin/IBMX treatments and washes, an inhibitor of PKA, 
the ATP analogue H89, was added for 10 min. Then, a third 
round of forskolin/IBMX treatment was added. Despite inhibit-
ing PKAc activity, puncta formation still occurred, proving that 
PKAc activity was not necessary (Fig. 1 D, last image).
Another inhibitor of PKAc is the heat-stable PKI. To fur-
ther prove that the punctate pattern is independent of PKAc ac-
tivity, cells were transfected with RI-GFP, PKAc-mCherry, 
and PKI-CFP simultaneously (Fig. 1 E and Video 3). These 
cells were given one round of forskolin/IBMX treatment fol-
lowed by four washes of Opti-MEM. At the beginning, the cells 
showed a diffuse pattern, and then upon treatment, they pre-
sented a punctate pattern. However, in this case, the punctate 
pattern was not reversible when the drugs were removed, which 
indicated the inability of RI to reassociate with PKAc in the 
presence of PKI. Thus, although PKAc activity was not required 
for puncta formation, release of PKAc from the RI holoenzyme 
was necessary.
Fractionation experiments of MEFs reveal a 
migration of free RI to membranes
To establish whether the puncta corresponded to membranous 
organelles or to protein aggregates, fractionation experiments 
were implemented (Fig. 2 A). Prkar1a
+/+ MEFs were used to 
look at the migration of endogenous RI. At basal levels of 
cAMP, the majority of RI was in the cytosolic fraction. How-
ever, upon 60 min of forskolin/IBMX treatment, RI showed a 
significant shift to the membrane fraction. Meanwhile, no change 
in PKAc levels was seen. Under these conditions, RI and PKAc 
were not seen in the nuclear fraction. RI was also not present in 
the cytoskeletal fraction, which included all residual proteins 
and protein aggregates. Markers for each fraction were used to 
verify equal sample loading and to confirm minimal cross- 
contamination during subcellular fractionation. We performed 
the same experiment with Prkar1a
/ MEFs, overexpressing 
both GFP-tagged RI with mCherry-tagged PKAc (unpublished 
data). Likewise, an increase of RI levels in the membrane frac-
tion was observed after forskolin/IBMX treatment. These results 
confirmed that free RI was migrating to membranes and that 
free RI was not forming protein aggregates.
Colocalization experiments of RI
To determine which possible membranous organelles were asso-
ciated with free RI, commercially available antibodies were 
Overexpression of the RI isoforms showed a punctate pattern, 
whereas overexpression of the RII isoforms produced peri-
nuclear localization. Therefore, the punctate pattern was an RI 
isoform-specific phenotype but not unique to RI.
Free RI, but not the holoenzyme, is 
associated with punctate pattern
In normal resting cells, RI is predominantly present as an 
inactive heterotetramer. It has been shown that free RI and the 
RI holoenzyme localize to discrete locations. We therefore 
wondered whether it was free RI or the type I PKA holo-
enzyme that was forming puncta. To answer this question, we 
coexpressed  GFP-tagged  wild-type  RI  with  mCherry-tagged 
PKAc.  When  both  RI  and  PKAc  were  overexpressed  in 
Prkar1a
/ MEFs, RI localization was diffuse in the cyto-
plasm (Fig. 1 C, left). These results suggested that type I PKA 
holoenzyme did not form puncta.
To test whether the overexpressed RI could be recruited 
to puncta after its disassociation from PKAc, cells were treated 
with forskolin/IBMX to elevate cAMP levels. Forskolin, by ac-
tivating adenylyl cyclase, increases the intracellular levels of 
cAMP, whereas IBMX, a nonspecific inhibitor of phospho-
diesterases, prevents its breakdown. cAMP binds to RI and   
releases PKAc from the holoenzyme complex. Under these condi-
tions, the punctate pattern appeared (Fig. 1 C, right). However, 
when RI(R211K), which is defective in cAMP binding (Bubis 
et al., 1988; Herberg et al., 1996), was coexpressed with PKAc, 
no puncta were observed with or without forskolin/IBMX treat-
ment. Therefore, formation of puncta appears to require free 
RI. These results also confirm that overexpressed wild-type 
RI did not readily recruit endogenous PKAc, unlike the over-
expressed mutant, which binds to endogenous PKAc to form 
the holoenzyme (Fig. 1 C and see Fig. 5 B). Consistent with this 
data, overexpression of RI(R211K) alone did not result in a 
punctate pattern (unpublished data).
Live-cell imaging demonstrates that puncta 
formation is reversible
To follow the formation of the puncta, we performed live-cell 
imaging experiments with Prkar1a
/ MEFs transiently trans-
fected with RI-GFP and PKAc-mCherry (Fig. 1 D and Video 1). 
After 18 h of transfection, the cells were equilibrated in Opti-
MEM for 1 h and imaged live at 37°C on a confocal micro-
scope. The cells were treated through two rounds of forskolin/
IBMX with four washes of Opti-MEM in between treatments. 
Before treatment (baseline), both RI and PKAc displayed   
a diffuse pattern. Within 2 min of the first treatment, RI 
showed a punctate pattern. This phenotype was reversible as in-
dicated by the diffuse pattern within 4 min after the washout of 
drugs (postwash). The diffuse pattern suggested a reassociation 
of RI with PKAc. When the cells were treated with the second 
forskolin/IBMX  treatment,  the  punctate  pattern  reappeared, 
which was also reversible when the drugs were washed away 
again (shown in Video 1 but not in Fig. 1 D).
In a separate experiment, when cells were treated with 
forskolin/IBMX for 1.5 h and then washed three times with 
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incorporated into protein aggregates without actually labeling 
autophagosomes (Kuma et al., 2007), we also checked for co-
localization by staining for LC3 after autophagy induction. Like-
wise, we saw no evidence of colocalization between RI and 
endogenous LC3 (Fig. 2 B, bottom). Colocalization with lyso-
somes  (LysoTracker)  or  mitochondria  (apoptosis-inducing 
factor [AIF]) was also not observed (Fig. 2 C). When staining 
for peroxisomes using 70-kD peroxisomal membrane protein 
(PMP70), we found a partial overlap with GFP-tagged RI in 
used to stain various organelles in Prkar1a
/ MEFs and HeLa 
cells (Fig. 2, B–E). Attempts to see the localization of free endog-
enous RI were unsuccessful because of the lack of suitable 
antibodies for immunostaining RI, thus we used RI-GFP. 
Because it was previously reported that RI colocalized with 
autophagosomes (Mavrakis et al., 2006), these were the first 
organelles we checked. However, when we coexpressed RI-
GFP with light chain 3 (LC3)–mCherry, we saw no colocaliza-
tion (Fig. 2 B, top). Because transiently transfected LC3 can be 
Figure  2.  Disassociated  RI  localized  to  membranous  organelles,  and  some  organelles  were  ruled  out  from  costaining  with  organelle  markers.  
(A) Prkar1a
+/+ MEFs were treated with 20 µM forskolin (FSK)/200 µM IBMX and fractionated. Cytosol refers to the cytosolic fraction, mem refers to the 
membrane fraction, nuc refers to the nuclear fraction, and cytosk refers to the cytoskeletal fraction. (B, top) HeLa cells were transiently cotransfected with 
GFP-tagged RI (green) and mCherry-tagged LC3 (red). (bottom) Autophagy was induced in Prkar1a
/ MEFs, which were transiently transfected with 
GFP-tagged RI (green), and then autophagosomes (LC3) were stained (red). (C) Cells were transfected with GFP-tagged RI (green). Prkar1a
/ MEFs 
were stained for lysosomes (LysoTracker), mitochondria (AIF), and peroxisomes (PMP70), whereas HeLa cells were stained for early endosomes (EEA1). 
(D) Rhodamine-transferrin (Tfn) was used to follow the recycling pathway. (E) Texas red–EGF (EGF) was used to follow the degradative pathway, and cells 
were fixed at three different time points. EEA1 was stained so that a merge with EGF indicated early endosomes. Bars, 20 µm.JCB • VOLUME 193 • NUMBER 2 • 2011   352
both Prkar1a
/ MEFs and HeLa cells (unpublished data) but 
not enough to suggest a localization limited to peroxisomes.
We also transiently transfected HeLa cells with GFP-
tagged RI and stained for early endosomes (early endosome 
antigen 1 [EEA1]; Fig. 2 C, bottom). No overlap was detected, 
though the puncta were similar in size to EEA1 speckles. They 
were also very close and almost touching but not overlapping. 
Because the puncta were in such close proximity to EEA1, we 
looked for colocalization along the endosomal pathway. The re-
cycling pathway was marked using rhodamine-transferrin but 
no overlap was found (Fig. 2 D). A search for localization along 
the degradative pathway was achieved using Texas red–labeled 
EGF (Fig. 2 E). Cells were fixed at different time points after 
the uptake of EGF to follow the different stages of the endo-
somal pathway. A great amount of overlap between Texas red–
EGF and EEA1 at 10 min indicated that EGF localized to the 
early endosomes at that time point. However, no overlap be-
tween RI and EGF/EEA1 was seen, although close proximity 
was consistently observed.
Electron microscopy experiments reveal 
localization to MVBs
Because our immunostaining was unsuccessful in identifying 
the organelles to which RI-GFP localized, we used correlated 
light and electron microscopy for an ultrastructural analysis. We 
transiently transfected Prkar1a
/ MEFs with either GFP-
tagged  RI  alone  or  GFP-tagged  RI  and  mCherry-tagged 
PKAc (Fig. 3, A and B, respectively). A poststain with lead was 
performed before imaging to enhance the visualization of cell 
membranes. With the transfection of RI-GFP, we observed 
electron-dense particles in organelles, making antibody staining 
unnecessary. In both cases, we discovered a localization of 
RI-GFP to membranous organelles that resembled MVBs. As 
a control, we also looked at untransfected Prkar1a
/ MEFs 
that were treated with forskolin/IBMX (Fig. 3 C). No electron-
dense product was observed in the MVBs from these cells, 
further verifying that the aforementioned dark electron-dense 
material was correlated with RI-GFP. Thus, we found the 
localization of RI-GFP puncta to MVBs. However, this local-
ization was not a mechanism for its rapid degradation because 
we observed puncta that remained despite reintroducing holo-
enzyme formation conditions in live-cell imaging (Video 2).
Localization to MVBs is not caused  
by ubiquitination
Because ubiquitination of proteins is used as a sorting signal to 
MVBs (Katzmann et al., 2001; Reggiori and Pelham, 2001), we 
wondered whether the RI targeted to MVBs was ubiquitinated. 
The PEST sequence is one signal that is recognized by the ubiq-
uitin machinery, and RI has a potential PEST sequence in its 
linker region (Bergold et al., 1992) that has been correlated with 
its ubiquitination upon cAMP binding (Hegde et al., 1993).   
To test the involvement of this PEST sequence, we used a PEST 
Figure  3.  Ultrastructural  analysis  revealed  localization  of  RI-GFP  in 
MVBs. Light and electron microscopy pictures were correlated to look for 
the localization of GFP-tagged RI. (A and B, top) White/black arrows 
point to an MVB that was correlated. (bottom) The MVB is indicated by 
black squares. (bottom right) RI-GFP is the dark black area within the MVB 
indicated by a black arrow. (A) Prkar1a
/ MEFs were transfected with RI-
GFP (green). (B) Prkar1a
/ MEFs were cotransfected with RI-GFP (green) 
and PKAc-mCherry (red) and treated with 20 µM forskolin/200 µM IBMX.   
(C) Untransfected Prkar1a
/ MEFs were treated with 20 µM forskolin/ 
200 µM IBMX. An enlarged image of MVBs from within the black square is 
shown on the right. The MVBs are indicated by black arrowheads.
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unbiased screen of RI-interacting partners, including AKAPs. 
We used untransfected HEK 293 cells and HEK 293 cells 
that were stably expressing tandem affinity purification (TAP)–
tagged RI.
First, to validate the accuracy of our methods, cAMP resin 
was used on untransfected HEK 293 cells to find proteins that 
bind to all four R-subunit isoforms (Table I, first method). The 
cAMP resin was directly subjected to trypsin digestion instead 
of buffer elution because it proved difficult to elute RI from 
the cAMP resin. The digested peptides were then analyzed by 
mass spectrometry, and we considered a result as a true positive 
if it had at least two unique peptides. Three R-subunit isoforms 
were identified: RI, RII, and RII. Two AKAPs were also 
identified: AKAP9 and AKAP1.
We also used cAMP to find proteins that bind to all four 
R-subunit isoforms in the presence of stably transfected wild-
type RI (Table I, second method). The proteins that were iden-
tified included the same three R-subunit isoforms: RI, RII, 
and RII. In this case, though, three AKAPs were identified: 
AKAP11, AKAP9, and AKAP5. However, it was not clear 
which R-subunit isoforms bind to these proteins.
Therefore, to detect proteins associated with RI instead 
of the other isoforms, we used the TAP tag system, in which 
stably transfected TAP-tagged RI was purified with strepta-
vidin and calmodulin resins (Table I, third method). In this case, 
we expected to find RI, PKAc, and any protein that would 
bind to either RI or to the RI holoenzyme. Cell lysates were 
first bound to streptavidin resin, and then binding proteins were 
eluted and bound to calmodulin resin. As with the cAMP resin, 
proteins were not eluted from the calmodulin resin because of 
difficulty in disassociating TAP-tagged proteins from these 
beads. Instead, we ran the protein-bound calmodulin resin on an 
SDS-PAGE gel to separate any calmodulin that was attached to 
the beads. The gel pieces were digested and analyzed by mass 
spectrometry to identify proteins. Out of the three AKAPs that 
were identified when using cAMP alone, only one was detected 
using this technique, AKAP11.
To mimic the scenario from our microscopy experiments, 
we used the TAP tag system followed by cAMP to disassociate 
any PKAc (Table I, fourth method). From this method, we 
pulled out proteins that bound directly to free TAP-tagged RI. 
AKAP11 was the only AKAP detected, and the unique peptides 
covered almost the entire AKAP11 sequence (unpublished data). 
Therefore, our mass spectrometry results suggested that AKAP11 
is the best AKAP candidate responsible for the targeting of RI 
to MVBs. These results also demonstrated that binding of 
AKAP11 to RI is very robust, as it survived multiple stringent 
washes. Complete mass spectrometry data for all proteins that 
were pulled out under the aforementioned conditions are in-
cluded as supplemental tables (Table S1, Table S2, Table S3, 
and Table S4).
AKAP11 binds to RI in its free or 
holoenzyme form
To independently validate the interaction between AKAP11 and 
RI, we immunoprecipitated endogenous AKAP11 from un-
transfected HEK 293 cells using the AKAP11 antibody or rabbit 
sequence predictor to determine that mutating the proline-rich 
region would remove it. If the PEST sequence were involved in 
the localization of RI to MVBs, removing it would disrupt 
puncta formation. However, when we mutated the PEST sequence, 
the punctate pattern was still observed, indicating that the PEST 
sequence was not essential for targeting to MVBs (Fig. S2). In 
addition, mass spectrometry analysis of human embryonic kid-
ney (HEK) 293 cells overexpressing wild-type RI did not   
detect ubiquitination of RI (unpublished data). We also saw no 
evidence  of  higher  molecular  weight  ubiquitinated  forms  of 
RI in any of our Western blot analyses.
Localization of puncta is through  
AKAP binding
To deduce which region of RI was essential for puncta formation, 
we expressed two GFP-tagged truncation mutants, RI(1–93) and 
RI(93–381). RI(1–93) includes the D/D domain, whereas 
RI(93–381) includes the two cAMP-binding domains. A faint 
punctate pattern was observed with the RI(1–93) construct 
but not with the RI(93–381) construct (Fig. 4 A). Thus, the 
N-terminal part of RI was necessary for the punctate pattern. 
Because RII anchoring to membranous organelles occurs via 
AKAP binding at the D/D domain, we next tested whether an 
AKAP was involved in the recruitment of RI to MVBs.
Previously, it has been shown that several mutations in 
RI reduced its binding to a dual-specific AKAP1, D-AKAP1, 
in vitro (Banky et al., 1998). We introduced one of these muta-
tions (I27A) into Prkar1a
/ MEFs, and the punctate pattern 
disappeared (Fig. 4 B). This result provided evidence that for-
mation of the RI puncta required AKAP binding.
To test this theory further, GFP-tagged RI was coexpressed 
in Prkar1a
/ MEFs with mCherry-tagged peptide disruptors of 
AKAP binding (Fig. 4 C). These disruptors were derived from the 
C terminus of a dual-specific AKAP, D-AKAP2(623–662), which 
contains the PKA-binding motif. Residues identified for isoform 
specificity in a previous study (Burns-Hamuro et al., 2003) were 
mutated to make RI or RII selectivity. Coexpressing wild-type 
RI  with  the  RI/RII-selective AKAP  disruptor  resulted  in  no 
change to the punctate pattern. On the other hand, coexpressing 
wild-type RI with an RI-selective AKAP disruptor caused 
the punctate pattern to become diffuse. However, the punctate 
pattern remained in the presence of the RII-selective AKAP dis-
ruptor. Although it might have been expected that the punc-
tate pattern would become diffuse in the presence of the RI/RII- 
selective AKAP disruptor, the lack of change is not surprising.   
Burns-Hamuro et al. (2003) reported that D-AKAP2 binds with 
greater affinity to RII versus RI (Kd = 2.2 nM vs. 48 nM, re-
spectively); therefore, the nonspecific disruptor could naturally be 
more selective for RII because of its higher affinity to RII. 
Collectively, these results supported the notion that an RIspecific 
AKAP is involved in localizing RI to MVBs.
Mass spectrometry analysis reveals 
AKAP11 as a binding partner to 
disassociated RI
Because >50 AKAPs exist (Wong and Scott, 2004), we devel-
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Figure 4.  Disruption of AKAP binding removed the punctate pattern. (A) Control GFP empty vector, GFP-tagged wild-type (wt) RI, and GFP-tagged dele-
tion mutants, RI(1–93) and RI(93–381), were expressed in Prkar1a
/ MEFs. White arrows indicate a few of the faint puncta that were seen with the 
expression of RI(1–93)-GFP. (B) A mutation that has been reported to disrupt D-AKAP1 binding, RI(I27A), was GFP-tagged and expressed in Prkar1a
/ 
MEFs. GFP empty vector and GFP-tagged wild-type RI were included as controls. (C) mCherry empty vector or mCherry-tagged AKB domain from   
D-AKAP2 (RI/RII selective, RI selective, or RII selective) was coexpressed with GFP-tagged RI in Prkar1a
/ MEFs. Bars, 20 µm.355 Localization of RI to multivesicular bodies • Day et al.
Because AKAP11  displayed  a  punctate  pattern  only  if 
RI were punctate, we next addressed the question of whether 
AKAP11 is responsible for the targeting of RI to form puncta. 
If this were the case, knocking down AKAP11 by RNA inter-
ference should have an effect on the targeting of RI to MVBs. 
We thus treated Prkar1a
/ MEFs for 1–2 d with siRNA di-
rected against AKAP11 and observed that siRNA effectively 
knocked down nearly all of the endogenous protein (Fig. 6 C). 
After 1 d of siRNA treatment, cells were transfected with wild-
type RI-GFP and analyzed through Western blotting and 
fluorescence microscopy analysis. We observed that the levels 
of RI-GFP were unaffected by the knockdown of AKAP11 
(Fig. 6 C); however, cells knocked down for AKAP11 no longer 
displayed a punctate pattern of RI-GFP (Fig. 6 D). Collec-
tively, these data suggest that AKAP11 is responsible for the 
targeting of free RI to MVBs.
We thus propose a model for the targeting of free RI that 
is blocked by the formation of the holoenzyme or by the disruption 
of AKAP binding and is independent of PKAc activity (Fig. 7). 
According to this model, AKAP11 is associated with the RI 
holoenzyme when it is diffuse in the cytoplasm, and release of 
PKAc is required for recruitment of RI to MVBs. Thus, holo-
enzyme formation not only inhibits the catalytic activity of 
PKAc but also prevents the targeting of free RI to MVBs.
Discussion
Although the initial driving force for this study was to charac-
terize the distinct puncta that formed when the free RI subunit 
was expressed in mammalian cells, the finding that both free 
RI and the RI holoenzyme were associated with AKAP11 
was another important discovery. Whereas RII subunits are con-
stitutively localized to discrete areas in the cell through their 
tight binding to AKAPs, the RI subunits are typically diffuse 
in the cytoplasm and only recruited to specific sites in response 
IgG as a negative control. Samples were analyzed by Western 
blotting using antibodies for RI, PKAc, and AKAP11 (Fig. 5 A). 
AKAP11 bound to both the RI holoenzyme and free RI.   
Inversely, we immunoprecipitated FLAG-tagged constructs of 
RI that were transiently transfected into HEK 293 cells. As 
mentioned earlier, one mutation, RI(R211K), is defective in 
cAMP binding. Samples were analyzed by Western blotting 
using antibodies for AKAP11, PKAc, and FLAG (Fig. 5 B). 
Both wild-type and mutant RI interacted with AKAP11. As 
expected, a lower amount of PKAc was purified with wild-type 
RI versus RI(R211K) because RI(R211K) would remain in 
complex with PKAc, despite the basal levels of cAMP. Together 
with the mass spectrometry data, this information led us to de-
duce that AKAP11 binds tightly to both free RI and RI in 
complex with PKAc.
We also demonstrated the colocalization of AKAP11 with 
RI through immunofluorescence. HeLa cells and Prkar1a
/ 
MEFs were transiently transfected with RI-GFP and stained 
for endogenous AKAP11. As observed from Fig. 5 C, the 
punctate pattern of AKAP11 overlapped with a majority of the 
punctate pattern from RI-GFP, further suggesting their inter-
action at MVBs.
AKAP11 is responsible for the  
targeting of free RI
Because we ascertained that AKAP11 binds to RI and that free 
RI, but not the holoenzyme, is targeted to MVBs, we next con-
firmed the colocalization of AKAP11 with RI that was dis-
associated from PKAc. Prkar1a
/ MEFs were transiently 
transfected with RI-GFP and PKAc-mCherry. One set of cells 
was left untreated (Fig. 6 A), whereas the other set was treated 
with forskolin/IBMX (Fig. 6 B). Then, both sets were stained 
for endogenous AKAP11. Before treatment, AKAP11 showed a 
diffuse pattern. After treatment, AKAP11 displayed a punctate 
pattern that overlapped with a majority of the RI-GFP puncta.
Table I.  cAMP-binding proteins and AKAPs identified from mass spectrometry using different purification methods on HEK 293 cell lysates
Method/cell type Protein description IPI Number of hits Unique peptides
cAMP resin/untransfected PKA type I- R-subunit
PKA type II- R-subunit


















cAMP resin/stably transfected TAP-tagged  
wild-type RI
PKA type I- R-subunit
PKA type II- R-subunit






















Streptavidin and calmodulin resins/stably transfected  
TAP-tagged wild-type RI
















Streptavidin and cAMP resins/stably transfected  
TAP-tagged wild-type RI
PKA type I- R-subunit
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Figure 5.  AKAP11 binds to free RI and the RI holoenzyme. (A) Endogenous AKAP11 was immunoprecipitated from HEK 293 cells in the absence and 
presence of 20 µM forskolin (FSK)/200 µM IBMX. Samples from the lysate and from the elution of the immunoprecipitation (IP) were immunoblotted (IB) with 
antibodies against RI, PKAc, or AKAP11. (B) HEK 293 cells were transiently transfected with control FLAG empty vector, FLAG-tagged RI, or FLAG-tagged 
RI(R211K), an RI mutant that is defective in cAMP binding. Samples from the lysate and from the elution of the IP were immunoblotted with antibodies 
against AKAP11, PKAc, or FLAG. (A and B) The lanes marked Lysate were loaded with 5% of the total cell lysates. (C) HeLa cells and Prkar1a
/ MEFs 
were transiently transfected with GFP-tagged RI (green) and stained for endogenous AKAP11 (red). Bars, 20 µm.357 Localization of RI to multivesicular bodies • Day et al.
Figure 6.  AKAP11 targets free RI. (A) Prkar1a
/ MEFs were transiently cotransfected with GFP-tagged RI (green) and mCherry-tagged PKAc (red) and 
stained for endogenous AKAP11 (blue). (B) Prkar1a
/ MEFs were transiently cotransfected with GFP-tagged RI (green) and mCherry-tagged PKAc (red), 
treated with 20 µM forskolin (FSK)/200 µM IBMX, and then stained for endogenous AKAP11 (blue). (C) siRNA of AKAP11 effectively knocked down the 
levels of endogenous AKAP11 protein in Prkar1a
/ MEFs after 1–2 d. No effect on the expression level of transiently transfected RI-GFP was observed, 
as judged by immunoblotting of whole-cell extracts with antibodies against AKAP11, RI, Hsp90, or tubulin. (D) Knockdown of endogenous AKAP11 
disrupted the formation of RI-GFP puncta in Prkar1a
/ MEFs. Ctrl, control. wt, wild type. Bars, 20 µm.JCB • VOLUME 193 • NUMBER 2 • 2011   358
to stimuli, for example, through the activation of T lymphocytes 
(Levy et al., 1996) or addition of hydrogen peroxide (Brennan 
et al., 2006). Here, we show that the association of RI with 
AKAP11 defines a novel signaling mechanism for the RI 
subunit that is distinct from the RII subunits and separate from 
its function as a regulator of PKAc.
We disproved several of the conclusions from an earlier 
study that analyzed RI-GFP in cells (Mavrakis et al., 2006). 
Our data refuted their study of RI localization to autophago-
somes. Additionally, Mavrakis et al. (2006) claimed a statisti-
cally significant difference in the number of autophagosomes 
observed between Prkar1a
+/+ MEFs and Prkar1a
/ MEFs, 
which is contradictory to our data. Analysis of the number   
of autophagosomes as correlated by their volume density in 
the cytoplasm at the electron microscopy level produced no 
statistically  significant  difference  in  the  number  of  auto-
phagosomes between Prkar1a
+/+ MEFs and Prkar1a
/ MEFs 
(volume density is 1.5 and 1.4%, respectively). From looking 
at the number of autophagosomes in Prkar1a
/ MEFs at the 
light microscopy level, we discovered that cells with RI-
GFP  puncta  displayed  lower  induction  of  autophagy  com-
pared  with  cells  without  RI-GFP  puncta  (representative 
picture in Fig. 2 B, bottom merge). Therefore, we conclu-
sively proved that RI was not colocalizing with autophago-
somes,  and  the  loss  of  RI  did  not  affect  the  number  of 
autophagosomes in cells.
Instead, our electron microscopy results revealed the 
localization of RI to MVBs. MVBs can only be definitively 
identified at the ultrastructural level (Clague and Urbé, 2008), 
which could be the reason for our difficulty in detecting colocal-
ization through immunostaining, although we consistently saw 
close proximity to endosomes. We also determined that local-
ization to MVBs was unique to the free RI subunit, indepen-
dent of PKAc activity, and reversible by lowering intracellular 
levels of cAMP.
To elucidate the molecular basis for RI targeting to MVBs, 
we used several strategies to pinpoint that it was the AKAP-
binding site within the N terminus that was required and that 
the AKAP needed was AKAP11. Our analysis also identified 
AKAP11 as a highly selective AKAP for RI. Surprisingly, 
only the free RI subunit goes to MVBs, even though AKAP11 
appears to be associated with both the holoenzyme and the dis-
associated RI subunit.
AKAP11, first discovered as an anchoring protein almost 
15 yr ago (Lester et al., 1996), is a 220-kD protein that has been 
reported to bind to both RI and RII in testis (Reinton et al., 
2000); however, the interaction to RI has not been studied in 
other cell lines, and its significance has never been addressed. 
In our experiments, we deduced that RI(I27) was essential for 
binding with AKAP11 based on our mutagenesis experiments 
coupled with the recent structure of a D-AKAP2 peptide bound 
to RI. In this structure, a mutation of RI(I27) would affect 
Figure 7.  Free RI is recruited to MVBs by AKAP11. A model for the mechanism of targeting RI is depicted. AKAP11 binds to the RI holoenzyme. 
Upon activation of PKA, AKAP11 stays bound to RI, which is recruited to multivesicular bodies (MVBs). If the RI holoenzyme is not activated, as in the 
case of RI(R211K):PKAc, RI does not get targeted. Likewise, free RI is not targeted properly when AKAP11 binding is disrupted, as in the case with the 
RI(I27A) mutation or in the presence of RI-selective AKAP disruptors. R, RI; C, PKAc; wt, wild type.359 Localization of RI to multivesicular bodies • Day et al.
Therefore, in HEK 293 or HeLa cells, the binding of AKAP11 
to AQP2 may be the method by which the AKAP11:RI com-
plex is targeted to MVBs. AQP2 is not known to be expressed in 
MEFs, but in this cell line, another protein may be acting in a 
similar fashion to target AKAP11:RI to MVBs. Elucidating 
the molecular basis for targeting AKAP11:RI to MVBs is our 
next challenge.
Although other researchers have reported the association 
of RI with proteins, such as RSK1 (p90 ribosomal S6 kinase; 
Chaturvedi et al., 2006), RFC40 (Gupte et al., 2005), and cyto-
chrome c oxidase (Yang et al., 1998), we describe a unique sig-
naling paradigm for the RI subunit. Our model involves its 
dynamic and reversible recruitment to a specific organelle once 
it is disassociated from PKAc. We have known that the forma-
tion of the holoenzyme leads to the inactivation of PKAc, but 
we now discover that the holoenzyme also retains the RI subunit 
in a soluble signaling complex that prevents it from localizing to 
MVBs. The signaling complex, comprised of AKAP11 and RI, is 
constitutively present, but the dynamic recruitment of RI to 
MVBs requires the release of PKAc. AKAP11 has been sug-
gested to regulate the cell cycle and play a role in driving oral 
carcinogenesis (Garnis et al., 2005), whereas RI is involved in 
several different signaling pathways, cellular functions, and dis-
eases. Therefore, it is likely that AKAP11 directs some of the 
RI functions. Through our characterization of RI puncta, we 
begin to have a handle on examining the fate of the disassoci-
ated RI subunit, whether it is to compensate for excess PKAc 
levels, bind to other proteins to necessitate their translocation, 
or participate in the control of cell cycle and cell growth.
Materials and methods
Antibodies
The following antibodies were used for Western blot analysis: anti–RI 
(Transduction Laboratories), anti-PKAc (Transduction Laboratories), anti-
Hsp90 (Transduction Laboratories), antiprohibitin (Abcam), antihistone 
(Cell Signaling Technology), antivimentin (Abcam), anti-AKAP11 (gener-
ated by the laboratory of J. Scott, University of Washington, Seattle, WA), 
anti-AKAP11  (Abnova),  anti–FLAG  M2  (Sigma-Aldrich),  and  antitubulin 
(Sigma-Aldrich).
Cloning and expression of RI and other proteins
Human RI was subcloned from pCMV-SPORT6 (Invitrogen) into the HindIII–
KpnI site of the pEGFP C2 vector (Takara Bio Inc.) and into the BamHI–
HindIII site of the pNTAP vector (Agilent Technologies). Single site mutations 
were made in the full-length sequence by QuikChange mutagenesis (Agi-
lent Technologies). Truncated RI(1–93 and 93–381) was isolated by PCR, 
and the amplified cDNA was subcloned. Vectors for expression of mCherry- 
and FLAG-tagged proteins were generated as previously described (Eggers 
et al., 2009). RI was subcloned into the HindIII–KpnI site of a FLAG vec-
tor. D-AKAP2 constructs were subcloned into the EcoRI–XhoI site of the 
mCherry vector. All constructs were verified by sequencing. R-subunit iso-
forms cloned into A-kinase activity reporter vectors were provided by F. Ma 
(University  of  California,  San  Diego,  La  Jolla,  CA).  PKAc  tagged  with 
mCherry and PKI tagged with CFP were provided by R. Tsien (University of 
California, San Diego, La Jolla, CA). LC3 tagged with mCherry was 
provided by A. Gustafsson (San Diego State University, San Diego, CA).
Cell lines and culture conditions
HeLa  cells  were  obtained  from  the  American  Type  Culture  Collection. 
MEFs, immortalized by transformation with pBRSV encoding the SV40 
virus, were provided by G.S. McKnight (University of Washington, Seattle, 
WA) and M. Ginsberg (University of California, San Diego, La Jolla, 
CA). Cells were maintained in DME supplemented with 10% fetal bovine 
serum (HyClone), 2 mM GlutaMax (Invitrogen), and 100 U/ml penicillin 
binding to an AKAP because it disrupts the packing of RI(I35),   
a direct interactor to D-AKAP2 (Sarma et al., 2010). Most 
AKAPs  with  dual  specificity  have  a  25–100-fold  greater   
affinity for the RII versus RI isoforms (Herberg et al., 2000; 
Burns-Hamuro et al., 2003). Furthermore, the off rate of AKAPs 
with RI is typically fast, making it difficult to analyze protein 
binding through RI overlay assays. In contrast, we find the bind-
ing of AKAP11 to RI with our most stringent washes during 
purification (Fig. 5, A and B; and Table I), which led us to de-
duce the presence of a high affinity RI-specific binding site in 
AKAP11. Three putative A-kinase binding (AKB) motifs exist 
in AKAP11 (Reinton et al., 2000). Based on the nature of the 
amphipathic helix that is formed from each of these putative 
AKB motifs and the recently predicted requirements for AKAP 
binding to RI versus RII subunits (Sarma et al., 2010), we pre-
dict that one of the AKB motifs has the potential to bind exclu-
sively to RI: AKAP11(611–628).
Although the precise role of targeting RI to MVBs re-
mains to be established, it does not appear to simply be a mech-
anism for degradation. Although MVBs were initially identified 
as part of the degradative pathway for proteins (Felder et al., 
1990), it has now been discovered that MVBs also give rise to 
endosomal compartments that do not fuse with lysosomes, and 
subsequently, their cargo are not destined for degradation. For 
example, the major histocompatibility complex class II proteins 
accumulate in MVBs, but instead of being degraded, they are 
secreted from the cell upon fusion of the MVB with the plasma 
membrane (van Niel et al., 2006). Thus, MVBs can house pro-
teins in temporary storage compartments without eventual deg-
radation. We believe this is the case for the targeting of RI to 
MVBs. Because we saw a reversibility of puncta formation, we 
suspect that the functionality of targeting RI to MVBs is to 
keep RI in a holding pattern until the holoenzyme reforms or 
its presence is needed somewhere else in the cell. A closer ex-
amination of our live-cell videos revealed that the puncta were 
merging with each other. The electron microscopy pictures 
showed that some of the electron-dense RI-GFP appeared to 
be clinging to the MVB outer membrane, so it is possible that 
RI is associated with the membrane from the cytosolic side, 
and not all were enclosed in the lumen. Furthermore, we do not 
believe that RI is moving along the degradative pathway be-
cause of its lack of colocalization with lysosomes (Fig. 2 C, 
LysoTracker).
To our knowledge, this is the first study of RI localizing 
to MVBs, and AKAP11 has never been shown to target there. In 
rats, AKAP11 potentially targets to peroxisomes because of the 
final three amino acids CRL (Lester et al., 1996), but human 
AKAP11 does not contain these final residues. We ruled out the 
targeting of human AKAP11 to peroxisomes because partial 
overlap of a couple of puncta, possibly caused by chance, was 
seen in only a few cells either stained for PMP70 or stained for 
proteins with another peroxisomal targeting sequence—SKL 
(unpublished data). Another study suggested the possibility of 
AKAP11 as an endosomal AKAP because of its colocalization 
with aquaporin 2 (AQP2) near apical membranes (Okutsu et al., 
2008). AQP2 binds to AKAP11 (Okutsu et al., 2008) and is 
known to target to MVBs in kidney cells (Takata et al., 2008). JCB • VOLUME 193 • NUMBER 2 • 2011   360
ImageJ (Abramoff et al., 2004) to generate maximum intensity projection 
images (z = 30–40 slices; z step = 0.3 µm) and Photoshop (Adobe) to 
generate composite pictures.
Induction of autophagy
Autophagy was induced in cells by amino acid and glucose starvation   
using Earle’s balanced salt solution (Invitrogen) for 4 h at 37°C. Two lyso-
somal inhibitors, 1 µM pepstatin A (EMD) and 10 µM EST (EMD), were 
used to prevent the degradation of LC3-II.
Endosomal pathway
Recycling pathway. HeLa cells transfected with RI-GFP were serum starved 
in DME supplemented with 0.5% BSA for 2 h. Alexa Fluor 568 transferrin 
receptor (Invitrogen) was added to the cells at a final concentration of   
50 µg/ml for 1 h at 37°C. Cells were washed once with cold PBS, once 
with cold stripping buffer (500 mM NaCl and 0.5% acetic acid, pH 3.0) 
for 45 s, and two more times with cold PBS. Cells were fixed with 4% 
paraformaldehyde for 15 min at room temperature.
Degradative pathway. HeLa cells transfected with RI-GFP were   
serum starved in DME supplemented with 0.5% BSA for 6 h. Texas red– 
labeled EGF (Invitrogen), diluted in cold DME to a final concentration of   
1 µg/ml, was added to the cells. Unbound EGF was removed by washing 
in cold PBS. Prewarmed DME was added to the cells, and different time 




/ MEFs were grown on glass-bottom grid dishes. After 18 h of 
transfection (using Fugene 6), cells were fixed in 2% paraformaldehyde 
and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, so-
lution for 5 min at room temperature and then moved to ice for a duration 
of  30  min  for  optimal  cell  ultrastructural  preservation.  The  cells  were 
washed five times in ice-cold 0.1 M sodium cacodylate buffer, pH 7.4, and 
3 mM calcium chloride, each taking 2 min, to remove excess aldehydes. 
Cells were viewed with a confocal microscope (MRC-1024; Bio-Rad Labo-
ratories) using 488- and 568-nm laser excitations and a 40× water objec-
tive lens with an NA of 1.2 (confocal stacks of z = 37 slices; z step = 
0.36 µm). A transmitted image was viewed with either a 10 or 20× objec-
tive lens to determine the grid location. Images were acquired using Laser-
Sharp 2000 software (Bio-Rad Laboratories/Carl Zeiss). The cultured cells 
were postfixed in ice-cold 1% osmium tetroxide with 0.8% potassium ferro-
cyanide and 3 mM calcium chloride for 30 min, washed five times in   
double-distilled water for 2 min each to stop the osmium tetroxide reaction, 
and en bloc stained in ice-cold 2% uranyl acetate overnight to help in-
crease membrane contrast. Afterward, the cultured cells were dehydrated 
in an ethanol series for 3 min each, starting with 20, 50, 70, and 90%   
ethanol on ice and ending with four changes of 100% ethanol at room 
temperature. The dehydrated cells were infiltrated in a 1:1 ratio of absolute 
ethanol to epoxy resin (Durcupan ACM; Electron Microscopy Sciences) for 
30 min and then with three changes of epoxy resin (Durcupan ACM) for 1 h 
each.  Finally,  a  fourth  epoxy  resin  (Durcupan  ACM)  change  was  per-
formed, and immediately, the dish was placed in a vacuum oven at 60°C 
to be polymerized for 48–72 h. After polymerization, the coverslip was re-
moved from the dish, and plastic blocks were sawed out and glued onto 
dummy blocks. 80-nm ultrathin serial sections were prepared using an   
ultramicrotome  (Reichert–Jung  Ultracut  E;  American  Optical  Instrument 
Company) with a diamond knife (Diatome), and the sections were sup-
ported onto 200 mesh copper grids. The 80-nm sections were poststained in 
Sato’s lead for 1 min, and the stained sections were imaged using an elec-
tron microscope (JEM-1200EX II; JEOL) at 80 kV.
Pull-down experiments
Untransfected and stable HEK 293 cells were grown on Nunc dishes and 
harvested at 80% confluency in PBS. Cells were lysed in 50 mM Tris,   
pH 7.0, 150 mM NaCl, 1 mM EDTA, and 1% NP-40 by three freeze-thaw 
cycles.  Lysates  were  bound  to  8-AEA  ([2-aminoethylamino]adenosine)–
cAMP  resin,  streptavidin  and  calmodulin  resins,  or  streptavidin  and   
8-AEA–cAMP resin. 8-AEA–cAMP was purchased from BioLog. Proteins 
bound to streptavidin resin were eluted with streptavidin buffer, which con-
tains biotin (Agilent Technologies). Mass spectrometry analyses of proteins 
bound to cAMP or calmodulin resins are described in the next section.
Proteomics analysis
Proteins bound to cAMP resin. Proteins pulled down with cAMP beads were 
resuspended in 0.1 M ammonium bicarbonate. Reduction and alkylation 
of the sample was performed by adding DTT to a final concentration of   
and streptomycin (Invitrogen) under 8% CO2. Transfections were per-
formed with transfection reagent (Fugene 6; Roche) 1 d before imaging or 
with Lipofectamine 2000 (Invitrogen) 1 d before immunoprecipitation (IP). 
Stable cell lines of HEK 293 cells were generated by transfection with Lipo-
fectamine 2000, selected accordingly for geneticin resistance, and main-
tained  as  described  for  HeLa  cells  and  MEFs  with  the  addition  of   
500 µg/ml geneticin (Invitrogen) to the media.
Live-cell imaging
Prkar1a
/ MEFs were grown overnight on poly-d-lysine–coated glass-
bottom  dishes  (MatTek)  and  cotransfected  with  GFP-tagged  RI  and 
mCherry-tagged PKAc (Fig. 1 D, Video 1, and Video 2) or cotransfected 
with GFP-tagged RI, mCherry-tagged PKAc, and CFP-tagged PKI (Fig. 1 E 
and Video 3). 18 h after transfection, DME growth media were replaced 
with Opti-MEM (Invitrogen). cAMP levels were elevated by the addition of 
20 µM forskolin (Sigma-Aldrich) and 200 µM IBMX (Sigma-Aldrich) simul-
taneously at 37°C. PKA activity was inhibited by the addition of 10 µM 
H89 (Millipore). Live-cell imaging sessions were conducted in a heated 
(37°C), sealed, humidified, and CO2-equilibrated environmental chamber 
(WeatherStation; Precision Control) paired with a confocal laser-scanning 
microscope (FluoView1000; Olympus). Images were collected using an 
oil immersion 60× objective with an NA of 1.42 (Olympus). The data 
in Fig. 1 D, Video 1, and Video 2 were collected using 488- and 561-nm 
laser excitations, whereas the data in Fig. 1 E and Video 3 were collected 
using a 405-, 488-, and 561-nm laser excitations. Stacks of 25–30 slices 
(300-nm thick) were acquired using sequential scanning to prevent bleed 
through between channels. The collected volumes were processed using a 
customized ImageJ macro (written by O. Kwon, National Center for   
Microscopy and Imaging Research/Center for Research in Biological Sys-
tems, University of California, San Diego, La Jolla, CA) to generate a maxi-
mum intensity projection for each channel and time point and then merged 
into an AVI video.
Fractionation
Prkar1a
+/+ MEFs were grown on 15-cm Nunc dishes to 80% confluency. 
Prkar1a
/ MEFs were transfected using Lipofectamine 2000 and also 
grown to 80% confluency. One set was left untreated, whereas the other 
set was treated with 20 µM forskolin simultaneously with 200 µM IBMX for 
1 h at 37°C. Cells were harvested in 2 ml of cold PBS and fractionated 
with a cell compartment kit (Qproteome; QIAGEN). Western blots were 
run on samples using equal volume loads. All primary antibodies were 
used at a dilution of 1:1,000 except for anti-Hsp90 (1:2,000 dilution) and 
antiprohibitin (1:100 dilution).
Immunofluorescence
HeLa cells and Prkar1a
/ MEFs were grown overnight in poly-d-lysine–
coated glass-bottom dishes or on glass coverslips (Thermo Fisher Scien-
tific), transfected with GFP-tagged RI for 18–24 h, and fixed with 4% 
paraformaldehyde (Electron Microscopy Sciences) for 15 min at room tem-
perature. Prkar1a
/ MEFs, which were cotransfected with GFP-tagged 
RI and mCherry-tagged PKAc, were left untreated or treated with 20 µM 
forskolin simultaneously with 200 µM IBMX for 1 h at 37°C and fixed 
through the same method as cells transfected with GFP-tagged RI alone. 
All solutions used during the immunostaining were prepared in Dulbecco’s 
PBS (Mediatech). The following antibodies were used at 1:100 dilutions: 
anti-LC3 (Cell Signaling Technology), anti-AIF (Cell Signaling Technology), 
anti-PMP70 (Sigma-Aldrich), anti-EEA1 (Cell Signaling Technology), anti-
AKAP11 (generated by J. Scott, University of Washington, Seattle, WA), 
Cy5-labeled donkey anti–rabbit IgG antibodies (Jackson ImmunoResearch 
Laboratories, Inc.), and DyLight 649 (Jackson ImmunoResearch Laborato-
ries, Inc.). LysoTracker (Invitrogen) was used to visualize lysosomes. Cells 
were permeabilized in 0.2% Triton X-100 (Sigma-Aldrich) for 5 min at 
room temperature and blocked in 2% BSA (Sigma-Aldrich) followed by se-
quential incubations in primary and secondary antibodies. The method for 
staining LC3 was slightly altered: cells were permeabilized in 0.05% Triton 
X-100 for 15 min and blocked in 3% BSA. When using LysoTracker, cells 
were incubated with a probe diluted in prewarmed DME (final concentra-
tion of 50 nM) for 1 h at 37°C before fixation. Fixed cells were viewed 
with either a microscope (Axiovert 200M; Carl Zeiss) equipped with an oil 
immersion 40× objective with an NA of 1.3 (Carl Zeiss) and an electron 
microscopy charge-coupled device camera (Cascade II:512; Photometrics) 
or with a confocal laser-scanning microscope (FluoView1000) equipped 
with an oil immersion 60× objective with an NA of 1.42. Epifluorescent 
images were acquired with MetaFluor software (Molecular Devices), 
whereas  confocal  images  were  acquired  with  FluoView  ASW  1.7c   
software (Olympus). The collected confocal images were processed using 361 Localization of RI to multivesicular bodies • Day et al.
nontargeting siRNA Pool #2 was used as a negative control. Cells were 
analyzed 1–2 d after siRNA treatment. Any transfection of plasmid DNA 
was performed 24 h after siRNA treatment.
Quantitative Western blot
Prkar1a
+/+ MEFs and Prkar1a
/ MEFs were grown to 80% confluency 
on 10-cm Nunc dishes and transfected with empty GFP or GFP-tagged RI, 
respectively. After 16–18 h, cells were harvested with cold CE1 buffer (10 mM 
Hepes, 60 mM KCl, 1 mM EDTA, 1 mM DTT, 1% BSA, and 0.5% NP-40) 
and lysed with sonication. Lysates were spun down at 14,000 rpm for 5 min. 
Proteins from the supernatant were analyzed by Western blotting. Band in-
tensity levels were measured using the AlphaView Q software on an imag-
ing system (FluorChem Q; Cell Biosciences, Inc.).
Stereology
The volume density of autophagosomes was determined using stereologi-
cal observations similar to those previously described (Yuan et al., 2007) 
on electron microscopy images as follows. Point counting was used to de-
termine the volume densities by overlaying a 100-point square grid on 
each digitized image (4,033 × 6,010 pixels with a pixel size of 2.8 nm) 
in Photoshop. Observations were made at the points of intersection (15 × 
21 points) of the grid. First, the volume available for autophagosomes to 
occupy was counted on each image. This was accomplished by excluding 
those points lying on top of any nucleus present and any empty space, that 
is, space not occupied by the cytoplasm. Next, the points lying directly on 
top of autophagosomes were counted. The volume density of mitochondria 
was calculated by dividing the number of autophagosome points by the 
cytoplasm points.
Online supplemental material
Fig. S1 shows that puncta formation is not an artifact of RI-GFP over-
expression. Fig. S2 shows that ubiquitination of RI is not the signal for 
targeting to MVBs. Video 1 shows that RI puncta formation is reversible 
and independent of PKAc activity. Video 2 shows that RI puncta is not 
rapidly degraded, and formation is reversible for up to 3 h. Video 3 shows 
that RI puncta formation is not reversible in the presence of PKI. Table 
S1 lists the proteins identified to bind to all four R-subunit isoforms in un-
transfected HEK 293 cells. Table S2 lists the proteins identified to bind 
to all four R-subunit isoforms in HEK 293 cells that are stably expressing 
TAP-tagged RI. Table S3 lists the proteins identified to bind to TAP-tagged 
RI, which were free or in complex with PKAc, in HEK 293 cells that are 
stably expressing TAP-tagged RI. Table S4 lists the proteins identified to 
bind to free TAP-tagged RI in HEK 293 cells that are stably expressing 
TAP-tagged RI. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201010034/DC1.
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